Genus (LON:GNS) Announces Quarterly Earnings Results

Genus (LON:GNS) issued its quarterly earnings results on Thursday. The company reported GBX 110.30 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Genus had a return on equity of 9.70% and a net margin of 7.07%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Stock Down 3.3%

Shares of LON:GNS traded down GBX 74 during trading on Thursday, hitting GBX 2,160. The company’s stock had a trading volume of 543,824 shares, compared to its average volume of 769,729. The company has a market capitalization of £1.43 billion, a PE ratio of 30.42, a P/E/G ratio of 2.87 and a beta of 0.90. The business has a 50 day moving average price of GBX 2,223.11 and a two-hundred day moving average price of GBX 2,382.24. Genus has a fifty-two week low of GBX 1,943 and a fifty-two week high of GBX 3,220. The company has a debt-to-equity ratio of 51.73, a quick ratio of 1.08 and a current ratio of 2.25.

Insider Transactions at Genus

In other news, insider Celia Baxter acquired 2,336 shares of the company’s stock in a transaction on Friday, June 26th. The shares were bought at an average cost of GBX 2,140 per share, with a total value of £49,990.40. 0.71% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 3,350 price target on shares of Genus in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of GBX 3,216.67.

Key Stories Impacting Genus

Here are the key news stories impacting Genus this week:

• Positive Sentiment: £60 million share buyback: Genus launched a buyback programme, signaling management confidence in the business and potentially supporting earnings per share by reducing the number of shares outstanding. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: Profit growth and lower leverage: Preliminary FY26 results showed higher pretax profit, while debt reduction improved the company’s financial position. The results and buyback followed developments involving Genus’s China joint venture. Genus boosts profits, cuts leverage and launches £60m buyback after China JV
• Positive Sentiment: Analyst support: Berenberg reaffirmed its “buy” rating and set a GBX 3,350 price target, implying substantial upside from recent trading levels. An Investors Chronicle analysis also characterized the share-price weakness as a potential buying opportunity. Genus share price weakness offers buying opportunity
• Neutral Sentiment: Genus reported quarterly EPS of GBX 110.30, with a 7.07% net margin and 9.70% return on equity. These figures provide evidence of ongoing profitability, but the market reaction was driven more by forward guidance and revenue performance. Genus earnings report
• Negative Sentiment: Slower FY27 growth outlook: Management forecast moderate operating-profit growth for FY27, disappointing investors seeking stronger expansion and prompting the shares to weaken. Genus Shares Fall as Company Forecasts Moderate FY27 Operating Profit Growth
• Negative Sentiment: Revenue miss: FY26 revenue fell short of expectations despite higher profits, raising concerns about the pace and quality of future growth. Genus announces buyback as profits rise but shares drop on revenue miss

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.